Dividend Seeker.
Fund holdings lookup
Request failed

As of the latest SEC filings, TherapeuticsMD, Inc. (TXMD) is held by 13 institutional funds. The largest fund shareholder is VANGUARD TOTAL STOCK MARKET INDEX FUND (VTI), holding an estimated $493,520.34 in market value, representing a significant portion of its portfolio.

Funds holding TherapeuticsMD, Inc. (TXMD)

Source: SEC Form N-PORT institutional portfolio disclosures

Ticker:
TXMD
CIK:
0000025743
13 results
Fund Type Manager Weight Market Value Shares
Report Date
Filing Date
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
ETF Vanguard 0.00% $493,520.34 244,317 Mar 31, 2026 May 28, 2026
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
ETF Vanguard 0.00% $220,947.60 109,380 Mar 31, 2026 May 28, 2026
FSMAX
Fidelity Extended Market Index Fund
MF Fidelity 0.00% $151,917.20 67,220 Feb 28, 2026 Apr 24, 2026
FCFMX
Fidelity Series Total Market Index Fund
MF Fidelity 0.00% $34,623.20 15,320 Feb 28, 2026 Apr 24, 2026
BRSIX
Ultra-Small Company Market Fund
MF Independent / Boutique 0.03% $34,340.00 17,000 Mar 31, 2026 May 21, 2026
FSKAX
Fidelity Total Market Index Fund
MF Fidelity 0.00% $33,527.10 14,835 Feb 28, 2026 Apr 24, 2026
DFAC
Dimensional U.S. Core Equity 2 ETF
ETF Dimensional Fund Advisors 0.00% $9,845.04 4,826 Apr 30, 2026 Jun 29, 2026
GADVX
The Gabelli ABC Fund
MF GAMCO / Gabelli 0.00% $7,272.00 3,600 Mar 31, 2026 Jun 1, 2026
DFEOX
U.S. CORE EQUITY 1 PORTFOLIO
MF Dimensional Fund Advisors 0.00% $2,168.52 1,063 Apr 30, 2026 Jun 24, 2026
EMACX
Enterprise Mergers and Acquisitions Fund
MF GAMCO / Gabelli 0.00% $2,020.00 1,000 Mar 31, 2026 Jun 1, 2026
-
Diversified Equity Master Portfolio
ETF Independent / Boutique 0.00% $1,504.90 745 Mar 31, 2026 May 28, 2026
DFQTX
U.S. CORE EQUITY 2 PORTFOLIO
MF Dimensional Fund Advisors 0.00% $852.72 418 Apr 30, 2026 Jun 24, 2026
GUG
Guggenheim Active Allocation Fund
CEF Guggenheim 0.00% $103.96 46 Feb 27, 2026 Apr 29, 2026
Advertisement (320x50)